|
| 新华制药(000756)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-04-14 | 3709.20 | 5.44% | 68025.50 | 215.26 | 44877.44 | 65.76% | 定向增发机构配售股份 | | 2023-05-09 | 24.09 | 0.04% | 63521.09 | 3867.67 | 44059.30 | 65.38% | 股权激励期权行权 | | 2023-01-11 | 426.03 | 0.63% | 63559.30 | 3829.45 | 44059.30 | 65.38% | 股权激励期权行权 | | 2022-01-13 | 516.78 | 0.82% | 43633.27 | 120.25 | 43633.27 | 68.98% | 股权激励期权行权 | | 2020-10-13 | 2735.28 | 4.40% | 42685.94 | 0.00 | 42685.94 | 68.64% | 增发A股法人配售上市 | | 2010-06-07 | 16492.07 | 36.06% | 30731.28 | 0.00 | 30731.28 | 67.20% | 股权分置限售流通 | | 2010-03-19 | 2286.56 | 5.00% | 14239.21 | 16492.07 | 30731.28 | 67.20% | 股权分置限售流通 | | 2007-06-06 | 1671.95 | 3.66% | 11952.65 | 18778.63 | 30731.28 | 67.20% | 股权分置限售流通 |
|